References
Copeland, R.A., Solomon, M.E. & Richon, V.M. Nat. Rev. Drug Discov. 8, 724–732 (2009).
Cherblanc, F., Chapman-Rothe, N., Brown, R. & Fuchter, M.J. Future Med. Chem. 4, 425–446 (2012).
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E. & Imhof, A. Nat. Chem. Biol. 1, 143–145 (2005).
Iwasa, E., Hamashima, Y. & Sodeoka, M. Isr. J. Chem. 51, 420–433 (2011).
Tibodeau, J.D., Benson, L.M., Isham, C.R., Owen, W.G. & Bible, K.C. Antioxid. Redox Signal. 11, 1097–1106 (2009).
Cook, K.M. et al. J. Biol. Chem. 284, 26831–26838 (2009).
Cherblanc, F. et al. Chemistry 17, 11868–11875 (2011).
Iwasa, E. et al. J. Am. Chem. Soc. 132, 4078–4079 (2010).
Takahashi, M. et al. J. Antibiot. (Tokyo) 65, 263–265 (2012).
Acknowledgements
We would like to acknowledge Cancer Research UK for funding (grant C21484A6944).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cherblanc, F., Chapman, K., Brown, R. et al. Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. Nat Chem Biol 9, 136–137 (2013). https://doi.org/10.1038/nchembio.1187
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1187
- Springer Nature America, Inc.
This article is cited by
-
Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically
Nature Communications (2022)
-
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
Oncogene (2020)
-
Venom alkaloids against Chagas disease parasite: search for effective therapies
Scientific Reports (2020)
-
ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
Cell Death & Disease (2019)
-
The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma
Cell Death & Disease (2019)